Your browser doesn't support javascript.
loading
Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1.
Pfeifer, H; Cazzaniga, G; van der Velden, V H J; Cayuela, J M; Schäfer, B; Spinelli, O; Akiki, S; Avigad, S; Bendit, I; Borg, K; Cavé, H; Elia, L; Reshmi, S C; Gerrard, G; Hayette, S; Hermanson, M; Juh, A; Jurcek, T; Chillón, M C; Homburg, C; Martinelli, G; Kairisto, V; Lange, T; Lion, T; Mueller, M C; Pane, F; Rai, L; Damm-Welk, C; Sacha, T; Schnittger, S; Touloumenidou, T; Valerhaugen, H; Vandenberghe, P; Zuna, J; Serve, H; Herrmann, E; Markovic, S; Dongen, J J M van; Ottmann, O G.
Afiliação
  • Pfeifer H; Department of Medicine, Hematology/Oncology, Goethe-University, Frankfurt, Germany. h.pfeifer@em.uni-frankfurt.de.
  • Cazzaniga G; Pediatric Clinic, University of Milan Bicocca, San Gerardo Hospital, Monza, Italy.
  • van der Velden VHJ; Department of Immunology, Erasmus MC, University, Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Cayuela JM; Hematology Laboratory and EA3518, University Hospital Saint-Louis, University Paris Diderot, Paris, France.
  • Schäfer B; Kinderspital Zürich, Onkologie Diagnostik Labor, Zürich, Switzerland.
  • Spinelli O; Hematology and Bone Marrow Transplant Unit, ASST-Papa Giovanni XXIII, Bergamo, Italy.
  • Akiki S; Regional Genetics Laboratory, Birmingham Women´s NHS Foundation Trust, Birmingham, UK.
  • Avigad S; Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
  • Bendit I; Division of Hematology and Hemotherapy, Medical School, University of São Paulo, São Paulo, Brazil.
  • Borg K; Department of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Cavé H; Department of Genetic Biochemistry, Hopital Robert Debré, Paris, France.
  • Elia L; Department of Hematology, Laboratory of Molecular Biology, University La Sapienza, Roma, Italy.
  • Reshmi SC; Institute for Genomic Medicine, Nationwide Children's Hospital and the Ohio State University, Columbus, OH, USA.
  • Gerrard G; Imperial Molecular Pathology, Centre for Hematology, Imperial College London, London, UK.
  • Hayette S; Laboratory of Molecular Biology and UMR5239, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite, Lyon, France.
  • Hermanson M; Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Juh A; Division of Pediatric Hematology/Oncology, Department of Pediatrics, National University Hospital, Singapore, Singapore.
  • Jurcek T; Department of Internal Medicine-Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
  • Chillón MC; Department of Hematology, University Hospital of Salamanca (IBSAL) & Cancer Research Centre-IBMCC, (Salamanca University-CSIC), Salamanca, Spain.
  • Homburg C; Department of Experimental Immunhematology/Immuncytology, Sanquin Diagnostics, Amsterdam, The Netherlands.
  • Martinelli G; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Kairisto V; TYKSLAB, Laboratory of Molecular Genetics, Turku University Hospital, Turku, Finland.
  • Lange T; Abteilung für Hämatologie und internistische Onkologie, Universität Leipzig, Leipzig, Germany.
  • Lion T; Childrens Cancer Research Institute, Labdia Labordiagnostik and Medical University, Vienna, Austria.
  • Mueller MC; III. Medizinische Klinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany.
  • Pane F; Azienda Ospedaliera Universitaria Federico II di Napoli Università, Naples, Italy.
  • Rai L; Department of Hematology, Royal Free Campus, University College London, London, United Kingdom.
  • Damm-Welk C; Department of Pediatric Hematology and Oncology, University Hospital, Justus Liebig University Giessen, Giessen, Germany.
  • Sacha T; Hematology Department, Jagiellonain University Krakow, Krakow, Poland.
  • Schnittger S; MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, Munich, Germany.
  • Touloumenidou T; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Valerhaugen H; Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Vandenberghe P; Center for Human Genetics, University Hospital Leuven and KU Leuven, Leuven, Belgium.
  • Zuna J; CLIP, Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University and UH Motol, Prague, Czech Republic.
  • Serve H; Department of Medicine, Hematology/Oncology, Goethe-University, Frankfurt, Germany.
  • Herrmann E; Institut für Biostatistik und Mathematische Modellierung, Goethe Universität, Frankfurt, Germany.
  • Markovic S; Department of Medicine, Hematology/Oncology, Goethe-University, Frankfurt, Germany.
  • Dongen JJMV; Department of Immunology, Erasmus MC, University, Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Ottmann OG; Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, Leiden, The Netherlands.
Leukemia ; 33(8): 1910-1922, 2019 08.
Article em En | MEDLINE | ID: mdl-30858550
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromossomo Filadélfia / Proteínas de Fusão bcr-abl / Guias de Prática Clínica como Assunto / Leucemia-Linfoma Linfoblástico de Células Precursoras / Reação em Cadeia da Polimerase em Tempo Real Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromossomo Filadélfia / Proteínas de Fusão bcr-abl / Guias de Prática Clínica como Assunto / Leucemia-Linfoma Linfoblástico de Células Precursoras / Reação em Cadeia da Polimerase em Tempo Real Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha